v3.25.2
STOCKBASED COMPENSATION (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Feb. 27, 2023
Jun. 29, 2025
Jun. 30, 2024
Stock options granted during the period     216,000
Exercise price of options granted   $ 0 $ 1.61
Stock based compensation $ 265,000 $ 93,735 $ 110,000
Projected stock-based compensation expense   $ 36,000  
Risk-free rate 4.40%    
Volatility 63.00%    
Granted Options to purchase 250,000    
Purchase price per shares $ 8.50    
Trading days 20    
Employees And Director [Member]      
Descrition of annual installments agreement   the Board approved a grant of 37,500 stock options with an exercise price of $1.50 per share. This grant included 17,500 fully vested options and 20,000 options vested 20% on the date of grant and 20% vesting on each of the following four anniversary dates  
2019 Plan      
Number of shares remaining available for grant   775,750  
2025      
Projected stock-based compensation expense   $ 12,000  
2026      
Projected stock-based compensation expense   $ 41,000  
In 2023 [Member]      
Description of Consultant warrants purchase   consultant a warrant to purchase 100,000 shares at $2.50 per share for seven years. The warrant vests monthly over five years  
Descrition of consulting agreement   we project that approximately $112,000 in stock-based compensation will be recognized at $32,000 per year in each of the next three years, and $16,000 will be recognized in 2028  
Stock based compensatisation 2022      
Stock options granted during the period   216,000  
Option purchase price   $ 2.58  
Stock based compensatisation 2022 | Officers      
Stock options granted during the period   175,000  
Stock based compensatisation 2022 | Employees      
Stock options granted during the period   41,000  
Stock based compensatisation 2024      
Stock options granted during the period   15,000  
Exercise price of options granted   $ 1.61  
Option vested   5,000  
Option purchase price   $ 1.70